UPDATED EFFICACY AND SAFETY OF ORAL ERDAFITINIB IN PATIENTS WITH BACILLUS CALMETTE-GUÉRIN–UNRESPONSIVE, HIGH-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2 COHORT 2
J.W.F. Catto, S.A. Hussain, B. Tran, Géraldine Pignot, Viraj Master, M. Rouprêt, Andrea Tubaro, Nobuaki Shimizu, N. Vasdev, H. Nishiyama, S. Daneshmand, Yuji Miura, Piotr L Chlosta, H.J. Cutuli, M. Luz, L. Crow, V. Naini, Spyros Triantos, M. Baig, G. Steinberg
{"title":"UPDATED EFFICACY AND SAFETY OF ORAL ERDAFITINIB IN PATIENTS WITH BACILLUS CALMETTE-GUÉRIN–UNRESPONSIVE, HIGH-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2 COHORT 2","authors":"J.W.F. Catto, S.A. Hussain, B. Tran, Géraldine Pignot, Viraj Master, M. Rouprêt, Andrea Tubaro, Nobuaki Shimizu, N. Vasdev, H. Nishiyama, S. Daneshmand, Yuji Miura, Piotr L Chlosta, H.J. Cutuli, M. Luz, L. Crow, V. Naini, Spyros Triantos, M. Baig, G. Steinberg","doi":"10.1016/j.urolonc.2024.01.161","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":506909,"journal":{"name":"Urologic Oncology: Seminars and Original Investigations","volume":"6 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology: Seminars and Original Investigations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.urolonc.2024.01.161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
